[1. R. V. Chambhare, B. G. Khase, A. S. Bobde and R. H. Bahekar, Synthesis and preliminary evaluation of some N-[5-(2-furanyl)-2-methyl-4-oxo-4H-thieno[2,3-d]pyrimidin-3-yl]carbox-amide and 3-substituted-5-(2-furanyl)-2-methyl-3H-thieno[2,3-d]pyrimidin-4-ones as antimicrobial agents, Eur. J. Med. Chem. 38 (2003) 89-100; DOI: 10.1016/S0223-5234(02)01442-3.10.1016/S0223-5234(02)01442-3]Search in Google Scholar
[2. B. V. Ashalatha, B. Narayana, K. K. V. Raj and N. S. Kumari, Synthesis of some new bioactive 3-amino-2-mercapto-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-4(3H)-one derivatives, Eur. J. Med. Chem. 42 (2007) 719-728; DOI: 10.1016/j.ejmech.2006.11.007.10.1016/j.ejmech.2006.11.007]Search in Google Scholar
[3. Z. A. Hozien, A. A. Abdel-Wahab, K. M. Hassan, F. M. Atta and S. A. Ahmed, Synthesis of some biologically active agents derived from thieno[2,3-d]pyrimidine derivatives, Pharmazie 52 (1997) 753-758.]Search in Google Scholar
[4. H. N. Hafez, H. A. R. Hussein and A. B. A. El-Gazzar, Design, synthesis of substituted thieno[2,3-d] pyrimidine-2,4-dithiones and its S-glycosides analogues as potential antiviral and antibacterial agents, Eur. J. Med. Chem. 45 (2010) 4026-4034; DOI: 10.1016/j.ejmech. 2010.05.060.]Search in Google Scholar
[5. L. D. Jennings, S. L. Kincaid, Y. D. Wang, G. Krishna-Murthy, C. F. Beyer, J. P. Mc Ginnis, M. Miranda, C. M. Discafani and S. K. Rabindran, Parallel synthesis and biological evaluation of 5,6,7,8-tetrahydrobenzothieno[2,3-d]pyrimidin-4(3H)-one cytotoxic agents selective for p21-deficient cells, Bioorg. Med. Chem. Lett. 15 (2005) 4731-4735; DOI: 10.1016/j.bmcl.2005.07.072.10.1016/j.bmcl.2005.07.072]Search in Google Scholar
[6. Y. D. Wang, S. Johnson, D. Powell, J. P. McGinnis, M. Miranda and S. K. Rabindran, Inhibition of tumor cell proliferation by thieno[2,3-d]pyrimidin-4(1H)-one-based analogs, Bioorg. Med. Chem. Lett. 15 (2005) 3763-3766; DOI: 10.1016/j.bmcl.2005.05.127.10.1016/j.bmcl.2005.05.127]Search in Google Scholar
[7. T. Horiuchi, J. Chiba, K. Uoto and T. Soga, Discovery of novel thieno[2,3-d]pyrimidin-4-yl hydrazone- based inhibitors of cyclin D1-CDK4: synthesis, biological evaluation, and structure-activity relationships, Bioorg. Med. Chem. Lett. 19 (2009) 305-308; DOI: 10.1016/j.bmcl.2008.11.090.10.1016/j.bmcl.2008.11.090]Search in Google Scholar
[8. A. Angell, C. McGuigan, L. G. Sevillano, R. Snoeck, G. Andrei, E. De Clercq and J. Balzarini, Bicyclic anti-VZV nucleosides, Bioorg. Med. Chem. Lett. 14 (2004) 2397-2399; DOI: 10.1016/j.bmcl.2004.03.029.10.1016/j.bmcl.2004.03.029]Search in Google Scholar
[9. A. Brancale, C. McGuigan, B. Algain, P. Savy, R. Benhida, J.-L. Fourrey, G. Andrei, R. Snoeck, E. De Clercq and J. Balzarini, Bicyclic anti-VZV nucleosides: Thieno analogues retain full antiviral activity, Bioorg. Med. Chem. Lett. 11 (2001) 2507-2510; DOI: 10.1016/S0960-894X(01)00471-1.10.1016/S0960-894X(01)00471-1]Search in Google Scholar
[10. H. N. Hafez, A. B. A. El-Gazzar and G. A. M. Nawwar, Synthesis, biological and medicinal significance of S-glycosido-thieno[2,3-d]-pyrimidines as new anti-inflammatory and analgesic agents, Eur. J. Med. Chem. 45 (2010) 1485-1493; DOI: 10.1016/j.ejmech.2009. 12.056.]Search in Google Scholar
[11. A. B. A. El-Gazzar, H. A. R. Hussein and H. N. Hafez, Synthesis and biological evaluation of thieno[2,3-d]pyrimidine derivatives for anti-inflammatory, analgesic and ulcerogenic activity, Acta Pharm. 57 (2007) 395-411; DOI: 10.2478/v10007-007-0032-6.10.2478/v10007-007-0032-618165185]Search in Google Scholar
[12. H. N. Hafez, O. K. Al-Duaij and A. B. A. El-Gazzar, Design synthesis and pharmacological evaluation of new nonsteroidal anti-inflammatory derived from 3-aminobenzothieno[2,3-d] pyrimidines, Int. J. Org. Chem. 3 (2013) 110-118; DOI: 10.4236/ijoc.2013.32012.10.4236/ijoc.2013.32012]Search in Google Scholar
[13. H. N. Hafez and A. B. A. El-Gazzar, Design and synthesis of 3-pyrazolyl-thiophene, thieno[2,3-d] pyrimidines as new bioactive and pharmacological activity, Bioorg. Med. Chem. Lett. 18 (2008) 5222-5227; DOI: 10.1016/j.bmcl.2008.08.071.10.1016/j.bmcl.2008.08.07118783947]Search in Google Scholar
[14. C. J. Shishoo, V. S. Shirsath, I. S. Rathod, M. J. Patil and S. S. Bhargava, Design, synthesis and antihistaminic (H1) activity of some condensed 2-(substituted)-arylaminoethyl-pyrimidine-4-(3H)- ones, Arzneimittel-Forsch. 51 (2001) 221-231; DOI: 10.1055/s-0031-1300028.10.1055/s-0031-1300028]Search in Google Scholar
[15. M. Santagati, M. Modica, A. Santagati, F. Russo and S. Spampinato, Synthesis of amino-thienopyrimidine and thienotriazolopyrimidine derivatives as potential anti-convulsant agents, Pharmazie 51 (1996) 7-11.]Search in Google Scholar
[16. A. J. Folkes, K. Ahmadi, W. K. Alderton, S. Alix, S. J. Baker, G. Box, I. S. Chuckowree, P. A. Clarke, P. Depledge, S. A. Eccles, L. S. Friedman, A. Hayes, T. C. Hancox, A. Kugendradas, L. Lensun, P. Moore, A. G. Olivero, J. Pang, S. Patel, G. H. Pergl-Wilson, F. I. Raynaud, A. Robson, N. Saghir, L. Salphati, S. Sohal, M. H. Ultsch, M. Valenti, H. J. A. Wallweber, N. C. Wan, C. Wiesmann, P. Workman, A. Zhyvoloup, M. J. Zvelebil and S. J. Shuttleworth, The identification of 2-(1H-indazol-4-yl)-6-(4-methanesulfonyl-piperazin-1-ylmethyl)-4-morpholin-4-yl-thieno[3,2-d]pyrimidine (GDC-0941) as a potent, selective, orally bioavailable inhibitor of class I PI3 kinase for the treatment of cancer, J. Med. Chem. 51 (2008) 5522-5532; DOI: 10.1021/jm800295d.10.1021/jm800295d]Search in Google Scholar
[17. D. P. Sutherlin, L. Bao, M. Berry, G. Castanedo, I. Chuckowree, J. Dotson, A. Folks, L. Friedman, R. Goldsmith, J. Gunzner, T. Heffron, J. Lesnick, C. Lewis, S. Mathieu, J. Murray, J. Nonomiya, J. Pang, N. Pegg, W. W. Prior, L. Rouge, L. Salphati, D. Sampath, Q. Tian, V. Tsui, N. C. Wan, S. Wang, B. Q. Wei, C. Wiesmann, P. Wu, B.-Y. Zhu and A. Olivero, Discovery of a potent, selective, and orally available class I phosphatidylinositol 3-kinase (PI3K)/mammalian target of rapamycin (mTOR) kinase inhibitor (GDC-0980) for the treatment of cancer, J. Med. Chem. 54 (2011) 7579-7587; DOI: 10.1021/ jm2009327.10.1021/jm2009327]Search in Google Scholar
[18. M. R. Prasad, R. A. Raghuram, R. P. Shanthan, R. K. Subramanian, S. Meena and K. Madhavi, Synthesis and adenosine receptor binding studies of some novel tri-azolothieno-pyrimidines, Eur. J. Med. Chem. 43 (2008) 614-620; DOI: 10.1016/j.ejmech.2007.05.001.10.1016/j.ejmech.2007.05.001]Search in Google Scholar
[19. K. A. Chakraborti, B. Gopalakrishnan, M. E. Sobhia and M. Alpeshkumar, 3D-QSAR studies on thieno[3,2-d]pyrimidines as phosphodiesterase IV inhibitors, Bioorg. Med. Chem. Lett. 13 (2003) 1403-1408; DOI: 10.1016/S0960-894X(03)00172-0. 10.1016/S0960-894X(03)00172-0]Search in Google Scholar
[20. M. I. Crespo, L. Pages, A. Vega, V. Segarra, M. Lopez, T. Domenech, M. Miralpeix, J. Beleta, H. Ryder and J. M. Palacios, Design, synthesis and biological activities of new thieno[3,2-d]pyrimidines as selective type-4 phosphodiesterase inhibitors, J. Med. Chem. 41 (1998) 4021-4035; DOI: 10.1021/ jm981012m.10.1021/jm981012m9767640]Search in Google Scholar
[21. M. Sugiyama, T. Sakamoto, K. Tabata and H. Fukumi, Condensed thienopyrimidine. IV. Synthesis and gastric antisecretory activity of 2,3-dihydro-5H-oxazolothienopyrimidine derivatives, Chem. Pharm. Bull. 37 (1989) 2717-2722; DOI: 10.1248/cpb.37.2717.10.1248/cpb.37.27172611931]Search in Google Scholar
[22. A. Gangjee, Y. Qiu, W. Li and R. L. Kisliuk, Potent dual thymidylate synthase and dihydrofolate reductase inhibitors: Classical and nonclassical 2-amino-4-oxo-5-arylthio-substituted-6-methylthieno[ 2,3-d]pyrimidine antifolates, J. Med. Chem. 51 (2008) 5789-5797; DOI: 10.1021/jm8006933.10.1021/jm8006933389276918800768]Search in Google Scholar
[23. N. Pemberton, E. Chorell and F. Almqvist, Microwave-assisted synthesis and functionalization of 2-pyridones, 2-quinolones and other ring-fused 2-pyridones, Heterocycl. Chem. 1 (2006) 1-30; DOI: 10.1007/708_006.]Search in Google Scholar
[24. S. R. Jain and A. Kar, The antibacterial activity of some essential oils and their combination, Planta Med. 20 (1971) 118-123; DOI: 10.1055/s-0028-109967.]Search in Google Scholar
[25. M. J. Weinstein and G. H. Wagman, Plant-derived antibiotics in: Antibiotics Isolation, Separation and urification (Ed. L. A. Mitscher), Elsevier Scientific Publishing Company, Amsterdam 1978, p. 464.]Search in Google Scholar
[26. A. L. Barry and C. Thornsbery, Susceptibility testing, in: Manual of Clinical Microbiology (Ed. J. P. Lennette), American Society for Microbiology, Washington (DC) 1981, pp. 561-574.]Search in Google Scholar
[27. K. J. Ryan and C. G. Ray (Eds.), Sherris Medical Microbiology, 4th ed., McGraw Hill, New York 2004.]Search in Google Scholar
[28. K. M. Amin, M. M. Kamel, M. M. Anwar, M. Khedr and Y. M. Syam, Synthesis, biological evaluation and molecular docking of novel series of spiro [(2H,3H) quinazoline-2,10-cyclohexan]-4(1H)-one derivatives as anti-inflammatory and analgesic agents, Eur. J. Med. Chem. 45 (2010) 2117-2131; DOI: 10.1061/j.ejmech.2009.12.078.]Search in Google Scholar
[29. J. Zhang, D. Ren, Y. Ma, W. Wang and H. Wu, CuO nanoparticles catalyzed simple and efficient synthesis of 2,3-dihydroquinazolin-4(1H)-ones and quinazolin-4(3H)-ones under ultrasound irradiation in aqueous ethanol, Tetrahedron 70 (2014) 5274-5282; DOI: 10.1016/j.tet.2014.05.059.10.1016/j.tet.2014.05.059]Search in Google Scholar